Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-0916

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Resume La 11β-hydroxysteroide deshydrogenase de type 1 (11βHSD1) est une enzyme intervenant dans la transformation tissulaire de… Expand
Is this relevant?
2013
2013
AIMS To characterize pharmacokinetic parameters of MK-0916 and its safety and tolerability in lean, healthy male subjects… Expand
Is this relevant?
2013
2013
The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a target for novel type 2 diabetes and obesity therapies based… Expand
Is this relevant?
Review
2013
Review
2013
OBJECTIVE Metabolic syndrome (MetS) and Cushing's syndrome share common features. It has been proposed that increased… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Aim: We examined the effects of the 11β‐hydroxysteroid dehydrogenase type 1 (HSD1) inhibitor, MK‐0916, on the multiple components… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) may be involved in several abnormalities associated with the metabolic… Expand
Is this relevant?